ConductScience.org, home

Paper2364366

Clinical course of essential thrombocythemia in 147 cases.

Fenaux P and 5 others. Cancer, 1990. Cited by 260 papers, by iCite.

Cite this record

ConductScience Library. Clinical course of essential thrombocythemia in 147 cases. Papers, record 2364366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2364366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical course of essential thrombocythemia in 147 cases.
PubMed
Journal
Cancer
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
260
iCite
Relative citation ratio, by iCite
9.39
iCite
Revised in PubMed
2022-04-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fenaux PP
2Simon MM
3Caulier MTM T
4Lai JLJ L
5Goudemand JJ
6Bauters FF

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Thrombocythemia, EssentialMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Remission Induction
Thrombosis

Source PubMed

Download CSV of topics

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 260 citations.

PMIDTitleJournalYearIn PapersSource
41070066VFM-SSL-BMADCC-Framework: vision foundation model and self-supervised learning based automated framework for differential cell counts on whole-slide bone marrow aspirate smears.Front Med (Lausanne)2025https://conductscience.org/library/papers/41070066PubMed
39434013Newly diagnosed essential thrombocythemia leading to cardiogenic shock: a case report.BMC Cardiovasc Disord2024https://conductscience.org/library/papers/39434013PubMed
39053144Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events.Clin Appl Thromb Hemost2024https://conductscience.org/library/papers/39053144PubMed
37621813Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report.Cureus2023https://conductscience.org/library/papers/37621813PubMed
37209326Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms.Mol Biol Rep2023https://conductscience.org/library/papers/37209326PubMed
36979444Structural and Dynamic Differences between Calreticulin Mutants Associated with Essential Thrombocythemia.Biomolecules2023https://conductscience.org/library/papers/36979444PubMed
36654555Essential Thrombocytosis in Patients <40 Years Old With Acute Coronary Syndromes: A Not So Uncommon Underlying Diagnosis Often Overlooked.Cureus2022https://conductscience.org/library/papers/36654555PubMed
36652138Risk of thrombosis in essential thrombocythemia according to three prediction models: an external validation study.J Thromb Thrombolysis2023https://conductscience.org/library/papers/36652138PubMed
36561301Clinical characteristics and management of headache in patients with myeloproliferative neoplasms.Front Neurol2022https://conductscience.org/library/papers/36561301PubMed
36505839A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment.Front Oncol2022https://conductscience.org/library/papers/36505839PubMed
36187505A woman presenting with facial droop.J Am Coll Emerg Physicians Open2022https://conductscience.org/library/papers/36187505PubMed
35162937Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms.Int J Mol Sci2022https://conductscience.org/library/papers/35162937PubMed
34945099Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings?J Clin Med2021https://conductscience.org/library/papers/34945099PubMed
34507190Postoperative bleeding in essential thrombocytosis patients with colorectal cancer: Case report and literature review.Int J Surg Case Rep2021https://conductscience.org/library/papers/34507190PubMed
34430110Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders.Cureus2021https://conductscience.org/library/papers/34430110PubMed
33849034Antithrombotic Management in Ischemic Stroke with Essential Thrombocythemia: Current Evidence and Dilemmas.Med Princ Pract2021https://conductscience.org/library/papers/33849034PubMed
33824820Hemodynamic Instability in Emergency Department: Giant Rectus Sheath Hematoma and Point-of-Care Ultrasonography.Cureus2021https://conductscience.org/library/papers/33824820PubMed
33147902The 2020 revision of the guidelines for the management of myeloproliferative neoplasms.Korean J Intern Med2021https://conductscience.org/library/papers/33147902PubMed
32121664Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms.Cancers (Basel)2020https://conductscience.org/library/papers/32121664PubMed
31496912Thiol-disulphide Homeostasis in Essential Thrombocythemia Patients.J Med Biochem2019https://conductscience.org/library/papers/31496912PubMed

See all 52 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2364366

GET https://conductscience.org/api/papers/v1/2364366/cited_by?page=2